Functional Disorder Clinical Trial
Official title:
Developing a Psychological Understanding of Idiopathic Drop Attacks
NCT number | NCT03694769 |
Other study ID # | CAHSS1710/03 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | July 20, 2018 |
Est. completion date | May 1, 2019 |
Verified date | March 2020 |
Source | University of Edinburgh |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The aim of this project is to better understand the experiences of people who have idiopathic
drop attacks. These falls have no identified medical cause but can cause people injuries such
as bruising, facial injuries and, in some cases, broken bones. It can also make them worry
about having more falls, and the pain and embarrassment this would cause, and stop them from
going out. There has been very little research in this area and there are currently no
treatments.
In this study, ten people who experience idiopathic drop attacks will be interviewed at an
outpatient clinic to understand more about them and the falls. They will be asked in
particular about the period of time around when they started having the falls and whether
there are aware of any triggers. Participants will also be asked to write accounts of these
drop attacks, after they have happened, for a period of eight weeks. They will be asked to
describe what they were thinking and feeling, and how they felt in themselves before and
after the fall.
This information will allow the researcher to look at common experiences that people who
experience these falls have. This understanding could help to identify whether a
psychological approach to treatment could help individuals to manage and cope with this
condition.
Status | Completed |
Enrollment | 7 |
Est. completion date | May 1, 2019 |
Est. primary completion date | May 1, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Aged 18+ 2. Idiopathic drop attacks occurring 6+ times per year 3. Having previously completed extensive investigation into possible cause of drop attacks 4. Able to provide informed consent Exclusion Criteria: 1. Diagnosis which would provide an alternative explanation for drop attacks 2. Drop attacks due to malfunction of the lower limbs, changes in body or head posture, or vertigo. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Western General Hospital (NHS Lothian) | Edinburgh | Scotland |
Lead Sponsor | Collaborator |
---|---|
University of Edinburgh | NHS Lothian |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Semi-structured assessment interview | This audio-recorded 60-minute interview will follow the format of an initial psychological assessment and will allow discussion of presenting problems and relevant personal and social history. This will allow potential predisposing and precipitating factors to be identified. Participants' experiences of IDAs will also be discussed, focussing on thoughts, feelings and behaviour before and after the episodes. The participants will also be asked about the impact that these have had on their everyday functioning. | One hour | |
Secondary | Drop attack diary | Participants will be asked to write an account of any IDAs. They will be shown an example diary and will also be given a prompt sheet, asking them to recall any triggers, feelings, physical arousal, thoughts and behaviour both directly before and after the episode. This diary will be completed by participants as close to the episode as possible | 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04464447 -
Feasibility and Pilot Testing of Group-based ACT for Adolescents With Functional Somatic Syndromes
|
N/A | |
Enrolling by invitation |
NCT04935307 -
Central Processing of Odour Stimuli in Patients With Functional Somatic Disorder or MCS Compared to Healthy Controls
|
N/A | |
Recruiting |
NCT06232473 -
Patient Education and Duloxetine, Alone and in Combination, for Patients With Multisystem Functional Somatic Disorder
|
Phase 4 |